Mr. Speaker, in May of this year Health Canada took this particular drug off the market because of reported difficulties with cardiac problems.
We recognize that there are some Canadians who do not respond to alternative treatments or therapies. Health Canada is doing two things. First of all, it is trying to persuade the manufacturer to make it available on special access requests. So far it has not but discussions continue. Second, we have identified a generic form of the drug, Cisapride, that can also treat serious gastrointestinal conditions. I am happy to announce that a source of Cisapride has been identified and authorized release from this source is currently in progress.